Table 2 Patients’ characteristics (n = 173)
Number of patients (%) | |
|---|---|
Gender | |
Female | 82 (47) |
Male | 91 (53) |
Affected side | |
Left | 91 (53) |
Right | 82 (47) |
First SSNHL | 124 (72) |
Recurrent SSNHL | 49 (28) |
Audiogram pattern | |
Low-frequency | 9 (5) |
Mid-frequency | 12 (7) |
High-frequency | 63 (36) |
Flat | 55 (32) |
Total deafness | 34 (20) |
Contralateral ear | |
Normal hearing | 97 (56) |
Abnormal hearing | 40 (44) |
Tinnitus, additionally | |
Yes | 139 (80) |
No | 34 (20) |
Vertigo | |
Yes | 33 (19) |
No | 140 (81) |
Smoking | |
Yes | 24 (14) |
No | 149 (86) |
Charlson Comorbidity Index | |
Index = 0 | 121 (70) |
Index = 1 | 27 (16) |
Index = 2 | 19 (11) |
Index ≥ 3 | 6 (4) |
Vascular risk profile | |
Yes | 93 (54) |
No | 80 (46) |
Metabolic syndrome | |
Yes | 4 (2) |
No | 169 (98) |
Final absolute hearing gain (∆6PTA) | |
0 dB | 24 (14) |
1-19 dB | 110 (64) |
≥20 dB | 39 (23) |
Median, range | |
Age (years) | 64, 18-88 |
Interval onset to therapy (days) | 3.5, 0-28 |
Hearing loss, initial (6PTA; dB) | 42.5, 14.2-110 |
Hearing loss, final (6 PTA; dB) | 30, 0.8-105.8 |
Hearing gain, absolute (∆6PTA; dB) | 9, 0-100 |
Hearing loss, contralateral ear, initial (6PTA) | 17.5, 0-120 |